ArticleNPJ precision oncology2026
Multicentric data challenge for artificial intelligence-based classification of leukocytes: results from the CytologIA consortium.
Article in NPJ precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate morphological classification of blood leukocytes remains a cornerstone of hematological diagnostics but still relies on manual expertise, leading to variability across laboratories. The CytologIA data challenge was organized to benchmark artificial intelligence (AI) models for automated classification of normal and pathological leukocytes from peripheral blood smears. Twenty hematology laboratories from France, Belgium, and Switzerland contributed to a multicentric, expert-annotated database of 69,168 images encompassing 23 leukocyte classes. A total of 245 teams from academia, hospitals, and industry participated in the challenge. The top-performing model-combining a YOLOX-based detection module with an ensemble of transformer and convolutional classifiers-achieved a balanced accuracy of 0.94 on the hidden test set, markedly outperforming the baseline CNN (0.82). While abundant cell types such as neutrophils were identified with near-perfect accuracy (>0.97), rarer and morphologically overlapping categories remained challenging. All data and models were released openly on data.gouv.fr and GitHub to ensure full reproducibility. CytologIA represents the first large-scale, open, and collaborative AI benchmark in hematological morphology, establishing a new reference for the development of robust, transferable diagnostic algorithms across institutions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.